SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-091292
Filing Date
2010-10-05
Accepted
2010-10-05 09:15:37
Documents
6
Period of Report
2010-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c06622e8vk.htm 8-K 15992
2 EXHIBIT 4.1 c06622exv4w1.htm EX-4.1 72173
3 EXHIBIT 10.1 c06622exv10w1.htm EX-10.1 124030
4 EXHIBIT 10.2 c06622exv10w2.htm EX-10.2 63565
5 EXHIBIT 99.1 c06622exv99w1.htm EX-99.1 13828
6 GRAPHIC c06622p0662201.jpg GRAPHIC 32328
  Complete submission text file 0000950123-10-091292.txt   336031
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 101107784
SIC: 2834 Pharmaceutical Preparations